Healthcare -
Biotechnology - NASDAQ - US
$ 36.18
-6.8 %
$ 3.43 B
Market Cap
-14.65
P/E
Price Target
Average
--4.64%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
--26.04%
Net Income
Estimate
38.76%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Scholar Rock Holding Corporation
Wall Street analysts predict an average 1-year price target for SRRK of $34.5 , with forecasts ranging from
a
low of
$28 to a high of $42 .
SRRK Lowest Price Target
Wall Street Target
28 USD
-22.61%
SRRK Average Price Target
Wall Street Target
34.5 USD
-4.64%
SRRK Highest Price Target
Wall Street Target
42 USD
16.09%
REVENUE FORECAST
Revenue Forecast Chart SRRK
EBIT FORECAST
EBIT Forecast Chart SRRK
NET INCOME FORECAST
Net Income Chart SRRK